Provided by Tiger Trade Technology Pte. Ltd.

GT Biopharma Inc.

0.4142
+0.00611.49%
Volume:208.69K
Turnover:85.63K
Market Cap:13.07M
PE:-0.07
High:0.4185
Open:0.4100
Low:0.4043
Close:0.4081
52wk High:3.85
52wk Low:0.3915
Shares:31.55M
Float Shares:30.72M
Volume Ratio:9.74
T/O Rate:0.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.2484
EPS(LYR):-6.9370
ROE:-1377.41%
ROA:-125.85%
PB:2.26
PE(LYR):-0.06

Loading ...

Nov 13, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2020

Major Issues Report

8-K - Current report
Nov 04, 2020

Major Issues Report

8-K - Current report
Oct 06, 2020

Major Issues Report

8-K - Current report
Sep 22, 2020

Major Issues Report

8-K - Current report
Aug 18, 2020

[Rev.]Quaterly Report

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
Aug 14, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 24, 2020

Correspondence

CORRESP [Cover] - Correspondence
Jul 14, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Jul 09, 2020

Major Issues Report

8-K - Current report
Jun 23, 2020

Major Issues Report

8-K - Current report
Jun 19, 2020

Major Issues Report

8-K - Current report
Jun 10, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
May 29, 2020

Major Issues Report

8-K - Current report
May 18, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
May 15, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 27, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 04, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 16, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 14, 2019

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]